Last update:
Oncology & Cancer news
Medical research
A treatment for metastasis? Using ferroptosis to attack migrating cancer cells
A treatment for metastatic cancer—researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), the University of Innsbruck, the Massachusetts Institute of Technology (MIT) and Universität Würzburg have now ...
15 hours ago
0
43
Oncology & Cancer
Hormone therapy for breast cancer linked with lower dementia risk
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published in JAMA ...
15 hours ago
0
7
Scientists develop potential stealth cancer therapy
Sneaking by cancer's defenses, by disguising tumor-fighting antibodies inside the molecules cancer uses to nourish tumor growth, is the basis of a novel therapy from Yale Cancer Center researchers at the Yale School of Medicine ...
17 hours ago
0
39
Study reveals dual role of protein in cancer treatment
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response, offering ...
16 hours ago
0
2
Study uncovers unknown interaction between leukemic cells and immune cells
The protein STAT3 helps the immune system to recognize leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to a study at the Karl Landsteiner University of Health ...
14 hours ago
0
20
Many breast cancer survivors do not receive genetic testing, despite being eligible
As cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor, a new study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors ...
10 hours ago
0
0
New imaging guidelines for head and neck cancers, a step toward practice change
Newly published research in The Lancet Oncology lays the foundation for many patients with head and neck cancers to be treated with tailored therapies that are less invasive and to avoid major, potentially debilitating surgeries.
10 hours ago
0
0
Researchers discuss HER2-low and HER2-zero in breast cancer
A new editorial paper titled "HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity" has been published in Oncotarget.
11 hours ago
0
0
Q&A: Patterns and prognostications in immune-related adverse events from immunotherapy treatment
Yevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an Assistant Professor of Dermatology at Harvard Medical School, and Guihong Wan, Ph.D., an Instructor of Dermatology at ...
13 hours ago
0
1
Electronic patient-reported outcome tool reduces cancer care disparities
A University of California, Irvine, research team has developed and implemented an intervention to enhance cancer care support services for racial and ethnic minority patients undergoing chemotherapy.
14 hours ago
0
0
The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer
Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are two of the most common prostate conditions among elderly men, with a significant percentage experiencing one or both conditions. Prostate cancer is the most ...
10 hours ago
0
0
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved ...
10 hours ago
0
0
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver transplantation, hepatectomy, and ...
10 hours ago
0
0
Research shows some women in their 40s prefer to delay breast cancer screening
A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according to a study published online July 16 in the Annals of Internal Medicine.
18 hours ago
0
0
Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
Study reveals gene 'switched off' in early stages of pancreatic cancer allows rapid tumor growth and spread
Scientists at Nottingham Trent University, the University of Nottingham, Stanford University and the University of California and Cedars-Sinai Medical Center, Los Angeles, have found that the molecule "HNF4A" suppresses pancreatic ...
Jul 15, 2024
0
41
Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study
A study led by researchers at Brighton and Sussex Medical School (BSMS) has unveiled an approach to predicting the effectiveness of treatments for patients with diffuse large B-cell lymphoma (DLBCL), a common form of blood ...
Jul 15, 2024
0
8
Better together: Spatial arrangement of three immune cells is key to attacking tumors, study finds
There's a frustrating fact about today's immunotherapies for cancer. While sometimes they work beautifully—completely eliminating or greatly reducing cancer in particular patients—other times they don't work at all. It's ...
Jul 15, 2024
0
14
New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer
Colorectal cancer is the second leading cause of cancer deaths worldwide and the third most diagnosed cancer, affecting over a million people annually. The problem worsens if the tumor is metastatic, meaning it moves from ...
Jul 15, 2024
0
0
Entering the golden age for antibody-drug conjugates in gynecologic cancer
In an editorial, published in Oncoscience titled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer," researchers Michelle Greenman, Blair McNamara, Levent Mutlu, and Alessandro D. Santin from Yale ...
Jul 15, 2024
0
0
